SUMMARY The temporal changes in left ventricular performance and hypertrophy after valve replacement for mitral regurgitation (MR) or stenosis (MS) are unclear. We studied 16 patients with MR and 17 patients with MS using echocardiography before and serially after surgery for an average of 15 months. Before surgery, average end-diastolic and end-systolic dimensions (EDD and ESD, respectively) and left ventricular muscle cross-sectional area (CSA), an index of left ventricular mass, were significantly greater than normal in subjects with MR. After surgery, EDD fell significantly, from 6.40 ± 1.00 (SD) cm to 5.40 ± 1.44 cm (p < 0.01); ESD (3.94 ± 0.93 cm) remained essentially unchanged postoperatively; CSA (25.9 ± 6.9 cm2) decreased significantly to 22.0 ± 6.7 cm2 (p < 0.01). In patients with MS, EDD, ESD and CSA were normal and did not change significantly at any time after surgery. The left ventricular ejection fraction (EF) was normal in both groups preoperatively (MR group 0.68 ± 0.07, MS group 0.63 ± 0.11). After surgery, EF was significantly reduced in patients with MR, while in patients with MS it was unchanged.
(p < 0.01); ESD (3.94 ± 0.93 cm) remained essentially unchanged postoperatively; CSA (25.9 ± 6.9 cm2) decreased significantly to 22 .0 ± 6.7 cm2 (p < 0.01). In patients with MS, EDD, ESD and CSA were normal and did not change significantly at any time after surgery. The left ventricular ejection fraction (EF) was normal in both groups preoperatively (MR group 0.68 ± 0.07, MS group 0.63 ± 0.11). After surgery, EF was significantly reduced in patients with MR, while in patients with MS it was unchanged.
We separated MR patients into two subgroups. In 12 subjects (group 1) with preoperative EDD = 5.94 0.42 cm, ESD = 3.55 ± 0.43 cm, and EF = 0.70 ± 0.05, EF fell slightly by 6 months after surgery to 0.59 ± 0.10 (p < 0.01), but remained within the normal range. Concomitantly, left ventricular hypertrophy regressed, as CSA was 24.2 6.5 cm2 before and 18.6 ± 2.4 cm2 after surgery (p < 0.01). In contrast, in four subjects (group 2) with preoperative EDD = 8.07 ± 0.35 cm, ESD = 5.69 ± 0.70 cm, and EF = 0.57 ± 0.05, left ventricular function progressively deteriorated after surgery, with EF falling to 0.26 ± 0.06 (p < 0.01). In the latter group left ventricular hypertrophy did not regress (CSA = 31.5 ± 4.5 cm2 before and 31.9 ± 3.4 cm2 after surgery, NS). Techniques for myocardial preservation during mitral valve surgery did not differ between the MR and MS groups. In group 2 MR subjects, there was no evidence of intraoperative myocardial infarction.
We conclude that in patients with MR who have moderate left ventricular dilatation and a normal EF preoperatively, there is regression of myocardial hypertrophy and only minimal reduction of left ventricular percent shortening after mitral valve replacement. However, in patients with MR who exhibit before surgery an EDD > 7.00 cm, an ESD > 5.00 cm and a low normal or depressed EF, left ventricular shortening likely has become partially dependent on systolic afterload reduction through a low impedance leak; after mitral valve replacement, left ventricular EF becomes markedly impaired and chamber dilatation and myocardial hypertrophy persist.
LEFT VENTRICULAR FUNCTION in the presence of chronic volume overload represents a complex interaction between myocardial contractile state, fiber length, and afterload; in chronic mitral regurgitation the afterload is affected by the low impedance pathway to the left atrium via the regurgitation leak.1"8 However, the temporal response of the left ventricle to surgical correction of mitral valve leakage and relief of the volume overload on the left ventricle has not been fully documented. An unexpected worsening of left ventricular shortening has been reported by some authors early after operation,9 18 and intraoperative ischemic damage to the myocardium,'2 recurrent coronary microembolism,18 persistent rheumatic myocarditis,19' 20 and a relative increase in afterload on irreversibly depressed myocardial fibers21' 22 have all been implicated in this phenomenon. The regression of eccentric hypertrophy and its relation to the presence or absence of postoperative myocardial failure has not been studied in patients undergoing mitral valve replacement.
In this investigation we analyzed noninvasively the relation of preoperative left ventricular size, performance, and degree of eccentric hypertrophy to serial changes in left ventricular function after surgical correction of chronic mitral regurgitation. The results are compared with a group of patients with mitral stenosis who also underwent replacement or reconstruction of the mitral valve using similar operative techniques. the study protocol for at least 12 months. Patient enrollment was begun in January 1976, and follow-up studies extended through March 1978. Since some patients either refused to participate in the protocol or were geographically inaccessible, our data were not from consecutive patients undergoing mitral valve replacement. All patients were required to have minimal (< 30% diameter obstruction) or no coronary artery disease on selective coronary cineangiography. None of the patients had evidence of mitral prosthetic valve incompetence postoperatively.
Mitral Regurgitation
The 16 patients in this group (eight males and eight females) had a mean age of 48.3 years (range 24-72 years). All patients were felt to have chronic mitral regurgitation of severe degree (3 + or 4 +) on left ventricular cineangiography. In all subjects, no significant diastolic pressure gradient was recorded across the mitral valve; any gradient recorded across the aortic valve during systole was less than 10 mm Hg. Ten patients had chronic mitral regurgitation which was considered the result of rheumatic fever; four patients had ruptured chordae tendineae at surgery; one had myxoid degeneration of the mitral valve; and one patient had a cleft posterior leaflet, noted at surgery (table 1) .
Standard chest x-rays in this group of patients showed a mean cardiothoracic ratio of 0.57 + 0.09 (SD). On the 12-lead ECG nine of 16 patients met the Romhilt-Estes criteria for left ventricular hypertrophy.23 One patient was New York Heart Association (NYHA) functional class IV, 14 were class III and one was class II. In 13 of 16 patients, the mitral valve was replaced with a Hancock porcine heterograft; three other patients had a mitral valve reconstruction by annuloplasty or plication.
Mitral Stenosis
Seventeen patients were included in this group (four males and 13 females); the mean age was 51.8 years (range 30-76 years). These patients had an average mean diastolic gradient across the mitral valve of 16 ± 7 (SD) mm Hg at rest and an average calculated mitral valve orifice size of 1.04 ± 0.5 (SD) cm2. Three patients were class IV by NYHA classification, 12 were class III, and two were class II.
The average cardiothoracic ratio obtained from standard chest x-rays was 0.54 ± 0.05 (SD). In all cases the etiology of mitral stenosis was felt to be secondary to rheumatic valvulitis. In Echocardiograms and 12-lead ECGs were obtained preoperatively, at hospital discharge (Fl), at an average of 4 months (F2) (range 3-6 months), and at 14 months (F3) (range 9-26 months) after surgery. Starting with the general availability of first-pass radionuclide angiography at our institution we tried to perform this examination, in addition to the other noninvasive tests, to validate the accuracy of extent of left ventricular shortening measurements by echocardiography in patients after surgery.
Evaluation of Intraoperative Myocardial Damage
Blood for analysis of cardiac enzymes was obtained the day before surgery and serially at 8, 12, 24 and 48 hours after surgery. MB-CPK was identified by a fluorescent technique after being separated by electrophoresis on cellulose acetate strips; the percent MB-CPK was related to the total serum CPK and expressed in international units per liters (IU/1). 24 25 To obtain an approximation of the total amount of CPK released postoperatively, a curve was constructed by plotting each MB-CPK value (y) against its sampling time (t). The area under the curve was calculated by a formula which sums successive trapezoids:
where yi represents the MB-CPK value at time ti; the resultant MB-CPK curve value was expressed as IU x hr.2425 L Evaluation of Left Ventricular Size, Mass and Function Preoperative evaluation of left ventricular function was accomplished using left-heart catheterization and left ventricular cineangiography. The left ventricular cineangiograms were filmed single-plane in the right anterior oblique projection, or biplane in the anteroposterior and lateral projections and performed in mid-inspiration by selective injection of 50-60 ml of Renografin-76 (meglumine diatrizoate) into the left ventricle over 3-4 seconds. In 32 of 33 patients the angiographic images at end-diastole and end-systole were planimetered on an electromagnetic tablet, and non-calibrated left ventricular volumes were calculated using a standard ellipsoid of revolution reference figure. Ejection fraction (EF) was then calculated from the ratio of stroke volume to enddiastolic volume (EDV). In two of the three participating cardiac catheterization laboratories, a radiopaque cross-hatched grid is used for correction of distortion of nonparallel x-rays, and thus, absolute ventricular volumes could be calculated in 24 of 33 patients using the regression formula of Dodge II  III   IV   III  III  III  III  III  III  III  II  III  III  III  IV  IV  III   RV  RV  RV  RV  RV  RV  RV  RV  RV  RV  RV  RV  RV  RV  RV tSignificantly different from corresponding observation in mitral stenosis (p < 0.05).
IParadoxical septal motion.
Abbreviations: Fl = at hospital discharge; F2 = 4 months after valve surgery; F3 = 14 months after valve surgery; EDD = end-diastolic dimension; ESD = end-systolic dimension; PWTh = posterior wall thickness; CSA = muscle cross-sectional area Ad/EDD = fractional shortening; EF = ejection fraction; mVcf = mean velocity of minor axis shortening.
during the postoperative period when there may be distortion of the usual geometry of the left ventricle, EF was also determined by first-pass radionuclide angiography.29 Ninety-two first-pass radionuclide EFs were performed simultaneously with the echocardiographic examination. 10 (fig. 4, top panel fig. 4 , bottom panel).
Mitral Stenosis
Preoperatively, the mean values for Ad/EDD (0.35 ± 0.10), and EF (0.63 ± 0.11), were not significantly different from normal. Immediately after surgery there was a significant depression of these parameters (Ad/EDD: 0.28 ± 0.07; EF: 0.53 ± 0.12, p < 0.01) compared with preoperative values. At F2, however, Ad/EDD (0.31 ± 0.07) and EF (0.58 ± 0.10) had almost returned to preoperative levels. At F3,zAd/EDD (0.35 ± 0.10) and EF (0.63 ± 0.12) were no longer different from normal ( fig. 4, bottom panel) . The mitral stenosis and mitral regurgitation groups differed significantly from each other at F3 with respect to Ad/EDD and EF (p < 0.01).
Subgroups in Mitral Regurgitation
Compared with the patients who had mitral stenosis, patients with mitral regurgitation did not behave postoperatively as a homogeneous group. However, we could readily identify two subgroups, based on preoperative left ventricular size and extent of shortening and the postoperative trend of left ventricular function and hypertrophy. In these subgroups the preoperative observations were compared with the last available follow-up by paired t test.
Group I -Patients with EDD < 6.5 cm, ESD < 4.3 cm and CSA = 24.2 ± 6.5 cm2 (n = 12).
After surgery EDD (4.66 ± 0.57 cm, p < 0.001) and ESD (3.17 ± 0.46 cm, NS) returned to normal; CSA regressed to (18.6 ± 2.4 cm2,p < 0.01) and EF decreased significantly, from 0.70 ± 0.05 to 0.59 ± 0.10 (p < 0.01, fig. 6 ), but remained within normal limits (0.64 + 0.06). 34 Our own findings in patients undergoing valve replacement for aortic regurgitation also indicate a reduction of onefourth to one-third of the original muscle mass after successful valve replacement.35 However, similar to the patients in subgroup II in whom left ventricular hypertrophy failed to regress, Gault reported three patients with free aortic regurgitation and considerable left ventricular hypertrophy in whom left ventricular muscle mass failed to regress after valve replacement.36 Both groups had depression of myocardial performance after uneventful surgery. These findings suggest that reduction of ventricular dimensions and myocardial mass after correction of a volume overload may depend on normal or near-normal myocardial performance.
However, the amount of fibrous tissue present in the myocardium may constitute another variable determining regression of left ventricular mass. Fibrous tissue is laid down simultaneously with contractile protein in response to various stimuli, but may also occur as a diffuse scar resulting from rheumatic myocarditis or hypoxic injury.34 Since fibrous tissue does not readily undergo catabolic breakdown, its presence may preclude permanently LVM reduction after mitral valve replacement for mitral regurgitation.
In the presence of mitral stenosis, the left ventricle does not carry an added hemodynamic burden, and there is no obvious explanation for impaired preoperative left ventricular function in some patients. One possible cause is the immobilization of the posterobasal area of the left ventricle by a "rigid mitral valve complex."38 Postoperatively, the patients with mitral stenosis performed as a homogeneous group; by F3 the average values for ventricular function and dimensions were not different from normal, and no significant variance was detected throughout the postoperative course.
Because both groups of patients were comparable with respect to preoperative clinical class, etiology, and degree of surgical trauma, we chose mitral stenosis to serve as a "control" group for mitral regurgitation. If any of the mechanisms cited, i.e., persistent rheumatic myocarditis, atrial fibrillation, microembolization, or intraoperative damage, play an important role in poor surgical long-term results, one might expect a comparable incidence in both groups of patients. Also, since the patients in subgroup 2 with mitral regurgitation did not differ significantly from subgroup 1 and from those with mitral stenosis with respect to total cardiopulmonary bypass time, aortic cross-clamp time and the cooling procedure applied VOL 59, No 6, JUNE 1979 for protection of the myocardium during ischemic arrest, perioperative myocardial damage probably does not explain the phenomenon of progressive deterioration of left ventricular performance postoperatively in all cases. This conclusion is supported by serial ECGs, and MB-CPK curves obtained in three of the four subgroup 2 patients after surgery, which did not indicate significant perioperative myocardial necrosis.
In assessing the reliability of serial noninvasive measurement of ventricular dimension and performance, several sources of error must be considered. Inconsistency in placement and technique of handling the echocardiographic transducer may result in variation in the measurement of minor axis dimension. To minimize this potential source of error, a record was kept for each patient, listing the transducer position selected at the previous visit. Care was taken to reproduce the identical minor axis chord and largest ventricular dimension by scanning in the direction of both major and minor axes at each subsequent visit. Serial measurements of ventricular dimensions and performance are highly reproducible, provided these factors are taken into account. 39 Although septal dyskinesis is much less frequent and less severe after mitral valve surgery than after Moreover, all patients had returned to normal septal motion by F3.
In summary, serial noninvasive studies of left ventricular function in patients who undergo mitral valve replacement for chronic mitral regurgitation indicate that the presence preoperatively of low normal or depressed extent of shortening, in association with large elevations in EDD, (> 7.0 cm) and ESD (> 5.0 cm) portends progressive deterioration of left ventricular function, no change in chamber size, and no regression of myocardial hypertrophy postoperatively. By contrast, patients with supernormal or normal minor diameter shortening fraction, and moderate left ventricular dilatation, manifest persistent normal left ventricular shortening and reduced left ventricular size after surgery. Comparison of these patients with subjects undergoing mitral valve replacement for mitral stenosis, as well as use of methods for detection of myocardial necrosis, indicate that poor myocardial preservation intraoperatively does not contribute to sustained depression of left ventricular shortening postoperatively. We conclude that patients with chronic mitral regurgitation should undergo mitral valve replacement before irreversible dependence on afterload reduction has developed. Serial echocardiographic analyses should be helpful in identifying such patients.
